Literature DB >> 1637968

Sample size determination for case-control studies and the comparison of stratified and unstratified analyses.

J Nam1.   

Abstract

Woolson, Bean, and Rojas (1986, Biometrics 42, 927-932) present a simple approximation of sample size for Cochran's (1954, Biometrics 10, 417-451) test for detecting association between exposure and disease. It is useful in the design of case-control studies. We derive a sample size formula for Cochran's statistic with continuity correction which guarantees that the actual Type I error rate of the test does not exceed the nominal level. The corrected sample size is necessarily larger than the uncorrected one given by Woolson et al. and the relative difference between the two sample sizes is considerable. Allocation of equal number of cases and controls within each stratum is asymptotically optimal when the costs per case and control are the same. When any effect of stratification is absent, Cochran's stratified test, although valid, is less efficient than the unstratified one except for the important case of a balanced design.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1637968

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  6 in total

1.  Stratified Fisher's exact test and its sample size calculation.

Authors:  Sin-Ho Jung
Journal:  Biom J       Date:  2013-11-11       Impact factor: 2.207

2.  Clinical skills or high-tech MR in TIA patients: what makes the difference?

Authors:  Riccardo Altavilla; Sabrina Anticoli; Michele Pellizzaro Venti; Monica Acciarresi; Andrea Alberti; Valeria Caso; Cataldo D'Amore; Francesca Romana Pezzella; Michele Venti; Giancarlo Agnelli; Maurizio Paciaroni
Journal:  Neurol Sci       Date:  2018-08-28       Impact factor: 3.307

3.  Sample size requirements for case-control study designs.

Authors:  M D Edwardes
Journal:  BMC Med Res Methodol       Date:  2001-11-19       Impact factor: 4.615

4.  Pharmacy Diabetes Screening Trial: protocol for a pragmatic cluster-randomised controlled trial to compare three screening methods for undiagnosed type 2 diabetes in Australian community pharmacy.

Authors:  Ines Krass; Rob Carter; Bernadette Mitchell; Mohammadreza Mohebbi; Sophy T F Shih; Peta Trinder; Vincent L Versace; Frances Wilson; Kevin Mc Namara
Journal:  BMJ Open       Date:  2017-12-27       Impact factor: 2.692

5.  Electronic Alerts for Acute Kidney Injury Amelioration (ELAIA-1): a completely electronic, multicentre, randomised controlled trial: design and rationale.

Authors:  Marina Mutter; Melissa Martin; Yu Yamamoto; Aditya Biswas; Boian Etropolski; Harold Feldman; Amit Garg; Noah Gourlie; Stephen Latham; Haiqun Lin; Paul M Palevsky; Chirag Parikh; Erica Moreira; Ugochukwu Ugwuowo; Francis P Wilson
Journal:  BMJ Open       Date:  2019-06-01       Impact factor: 2.692

6.  Red cell distribution width as a surrogate marker of haemoglobinopathies in western Kenya.

Authors:  Benard M Mutua; George Sowayi; Patrick Okoth
Journal:  Afr J Lab Med       Date:  2022-04-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.